Ex-Officio Members of the Advisory Committee on Breast Cancer in Young Women

Agency for Healthcare Research and Quality: Camille Fabiyi, Ph.D., M.P.H.

Dr. Fabiyi is the Senior Advisor for Women’s Health and Gender Research within the Office of Extramural Research, Education, and Priority Populations (OEREP) at the Agency for Healthcare Research and Quality (AHRQ). In this role, she conducts, supports, and oversees research on women’s health, perinatal health and health disparities in the context of healthcare system quality and improvement and patient safety. She also provides leadership and represents AHRQ on all matters related to women’s health and gender research issues.  Prior to joining AHRQ, she served as a Senior Researcher in the Department of Obstetrics and Gynecology at the University of Chicago, where she conducted reproductive health research. Formerly, she served as the Project Director on federally funded research projects in the areas of maternal and child health and aging at the University of Illinois at Chicago (UIC). Dr. Fabiyi received her PhD in Community Health Sciences with a concentration in Maternal and Child Health and her MPH in Health Policy and Administration at the UIC School of Public Health.

Department of Health and Human Services Office on Women’s Health: Vacant

Indian Health Service: RADM Michael Toedt, M.D., F.A.A.F.P.

Rear Adm. Michael Toedt serves as the Chief Medical Officer of the Indian Health Service. The IHS, an agency within the Department of Health and Human Services, is the principal federal health care provider for 2.3 million American Indians and Alaska Natives who are members of 573 federally recognized Tribes. As the CMO, Dr. Toedt is IHS’s lead expert on medical and public health topics, provides national leadership for the clinical and community-based health programs of the agency, and serves as the primary liaison and advocate for IHS health professionals. Dr. Toedt previously served as CMO for the Nashville Area, and as Acting Chief Medical Information Officer for the IHS. He earned his Bachelor of Science in applied physics with honor from the Georgia Institute of Technology and his Doctor of Medicine from the Uniformed Services University of the Health Sciences. He completed residency in family medicine and fellowship in obstetrics at the Franklin Square Hospital Center in Baltimore. He has served on numerous IHS and interagency committees, published several peer-reviewed articles, and holds several medical school clinical teaching appointments. He is board certified in family medicine and maintains active clinical privileges at several IHS and tribal facilities.

National Institutes of Health: Jung-Min Lee, M.D.

Dr. Lee is the Assistant Clinical Investigator in the Women Malignancies Branch of the National Cancer Institute. Dr. Lee is a graduate of Yonsei University, Wonju College of Medicine in South Korea. She completed residency training in internal medicine at the Albert Einstein Medical College, followed by a clinical research fellowship on breast cancer functional imaging at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Lee came to the NCI for medical oncology training in the Medical Oncology Branch (MOB). Subsequently, she joined the Molecular Signaling Section/Women’s Cancers Clinic, MOB, to investigate potential biomarkers and develop rational combinations of targeted therapies for rare subsets of women’s cancers. Dr. Lee maintains her clinical focus in the development of early clinical trials for ovarian cancer and rare subsets of women’s cancers, such as BRCA1/2mut carriers with ovarian and/or breast cancers, or women with triple negative breast cancer (TNBC). Dr. Lee is a participating member in the Gynecologic Oncology Group, American Association for Cancer Research, American Society for Clinical Oncology, and the Breast and Gynecologic Malignancies Faculty of the CCR.

Page last reviewed: November 16, 2020